NIU’s Global Round-up: Bayer Consumer Health opens 1st R&D center in China, Baze expands in Europe, and more

By Stephen Daniells

- Last updated on GMT

© Getty Images / Burak Can Oztas
© Getty Images / Burak Can Oztas

Related tags Sports nutrition personalized nutrition European union

What's happened this week around the Nutra-Verse? Stay on top of things with our weekly round-up of key news from across the globe.


Baze readies for 2020 European debut 

Baze, which launched its DIY blood testing service to determine nutrient levels and deliver customized supplement packages in the US in 2018, is coming to Europe.     

“We are planning to launch in early 2020 in Europe,” ​Philipp Schulte, Baze CEO and co-founder, told NutraIngredients-Europe. “We are in discussions with European supplement makers and there is a great level of interest.”

The firm recently received $6m via a Series A fundraising round led by US supplements giant, Nature’s Way.

Despite its European origins and base, Baze launched in the US first via its Boston office because it reckoned the personalized nutrition market was more advanced there, but Schulte observed Europe was moving ahead, especially with the likes of Nestlé investing heavily in the sector.

“Europe has been a few years behind but it is catching up fast and we are very excited about launching here.”

For more on this story, please click HERE​.


Bayer opens first Chinese R&D center to tap growing sports nutrition and personalization trends

Bayer Consumer Health said the increasing awareness of self-care, rising living standards, ageing population, and healthier lifestyles of Chinese consumers had created a large opportunity for China’s health food market.

The company’s first APAC R&D Center is located in Qidong, Jiangsu Province in China and will focus on formulation and analytical development to produce new health foods to help consumers achieve better care in their daily health.

Wei Li, head of Bayer Consumer Health China Development Centre told NutraIngredients-Asia the center would house professionals from different scientific disciplines, such as pharmaceutical chemistry, biochemistry, chemical engineering, pharmaceutical engineering, etc to innovate health foods and accelerate new product launches.

“The Chinese consumer is evolving in a fast pace. China merits its own dedicated R&D facilities as we could be able to access local knowledge in terms of the consumer, the retail environment and to support local brands as well as introduce our global power brands to China,”​ added Sharon James, head of research & development at Bayer Consumer Health.

For more on this, please click HERE​.


Cycling © Getty Images torwai
© Getty Images / torwai

Brazil’s Active Pharmaceutica has teamed up with Netherlands-based BioActor to promote and distribute the Dutch company’s proprietary sports performance ingredient in Brazil.

Under their partnership agreement, Dutch BioActor will see its proprietary sports performance ingredient, WATTS’UP, targeted at, and distributed in, the compounding pharmacy market in Brazil.

Speaking about the partnership, BioActor’s CEO, Hans van der Saag, reveals that the duo first met at an event in Geneva, where Active Pharmaceutica was looking for a sports nutrition ingredient with clinical studies and strong science.

Identifying Brazil as its first entry point, van der Saag went on to explain that: The Brazilian market is rapidly growing and very demanding on the level of scientific substantiation.”

For more on this, please click HERE​.

Related news

Show more

Related products

show more

The solutions to botanical supply chain challenges

The solutions to botanical supply chain challenges

Content provided by Ayana Bio | 05-Jun-2024 | Infographic

Many botanicals continue to face supply chain challenges, from the surging demand for stress-relieving adaptogens and immune-support ingredients to the...



Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 30-May-2024 | Product Brochure

Nature's power is a gift, one that BIONAP knows how to use responsibly. From the very beginning of our work to the last detail, Biodiversity is what inspires...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

Related suppliers

Follow us


View more